Sign In
Buy NBIX
$165.11
+10.27 (+6.63%)
At Close: Jun 03, 2026
Neurocrine Biosciences to Participate at the William Blair Biotech Focus Conference 2020
08:01pm, Thursday, 30'th Jul 2020
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the William Blair Biotech Focus Conference 2020 at 12:00 p.m. ET on Thursday, August 6, 2020. Kyle Gano, Chief Business Development and
Charting a (bullish) holding pattern, S&P 500 digests break to 5-month highs
04:44pm, Tuesday, 28'th Jul 2020
The major U.S. benchmarks are acting well technically, though amid increasingly sideways late-July price action, writes Michael Ashbaugh.
Neurocrine Biosciences (NBIX) Reports Next Week: Wall Street Expects Earnings Growth
04:31pm, Monday, 27'th Jul 2020
Neurocrine (NBIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mizuho Boosts Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $127.00
06:44am, Monday, 27'th Jul 2020
Neurocrine Biosciences (NASDAQ:NBIX) had its price objective boosted by Mizuho from $105.00 to $127.00 in a report released on Thursday morning, The Fly reports. The brokerage currently has a neutral
Idorsia: A Unique Opportunity To Buy Discounted Shares
06:24pm, Tuesday, 21'st Jul 2020
A unique opportunity has developed for investors looking for a biotech to add to their portfolio. I will explain why the recent Cilag Holding decision has been misconstrued by some investors.
Charting a bull-flag breakout, S&P 500 extends rally as volatility recedes
04:24pm, Tuesday, 21'st Jul 2020
Technically speaking, the U.S. benchmarks’ bigger-picture backdrop remains bullish, and continues to strengthen, amid recently receding volatility, writes...
Three health-care stocks to watch as sector hits records
04:05pm, Tuesday, 21'st Jul 2020
Health-care stocks keep hitting highs. Mark Newton of Newton Advisors and Danielle Shay of Simpler Trading share their favorite names.
Frontier Capital Management Co. LLC Makes New Investment in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
07:02am, Monday, 20'th Jul 2020
Frontier Capital Management Co. LLC purchased a new position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exch
Metrica Partners Sends Letter to Board of NBI Industrial Finance
03:01am, Monday, 20'th Jul 2020Metrica Partners Sends Letter to Board of NBI Industrial Finance
12:00am, Monday, 20'th Jul 2020
Metrica Partners Pte. Ltd. (“Metrica”) manages investment funds that are among the largest minority shareholders of NBI Industrial Finance Co. Ltd. (“
Neurocrine Biosciences, Inc. to Post Q2 2020 Earnings of $0.39 Per Share, William Blair Forecasts (NASDAQ:NBIX)
01:32am, Saturday, 18'th Jul 2020
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) – Equities research analysts at William Blair increased their Q2 2020 earnings estimates for Neurocrine Biosciences in a note issued to investors on Thursd
National Bank of Canada : Investments announces changes to portfolio managers | MarketScreener
08:01pm, Friday, 17'th Jul 2020Building A 'No-Brainer' Portfolio Today: 3 Fundamental Elements
08:01pm, Wednesday, 15'th Jul 2020
You don't need to lock yourself into a particular kind of investing style (e.g., dividend). No one can stop you from holding both AMZN and AT&T at the same time.
'GILDing' the Lilly: COVID Progress in Spotlight Ahead of Health Sector Earnings
12:00am, Wednesday, 15'th Jul 2020
Stocks Analysis by JJ Kinahan covering: S&P 500, Eli Lilly and Company, Gilead Sciences Inc, Medtronic PLC. Read JJ Kinahan's latest article on Investing.com
